SBIR-STTR Award

HPLC interface for electrospray spectrometry
Award last edited on: 5/16/02

Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$50,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Marvin L Vestal

Company Information

Vestec Corporation

9299 Kirby Drive
Houston, TX 77054
   (713) 796-9677
   N/A
   N/A
Location: Single
Congr. District: 09
County: Harris

Phase I

Contract Number: 1R43GM044466-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1990
Phase I Amount
$50,000
The goal of this research is to develop and adapt Vestec Corporation's "Universal Interface" to couple conventional high-performance liquid chromatography (HPLC) to electrospray mass spectrometry. The interface, which has been successfully applied to coupling reversed-phase HPLC at flow rates as high as 1.5 ml/min of aqueous effluent to electron impact mass spectrometry, produces an aerosol of droplets containing the sample and allows removal of as much solvent as desired without losing the sample or destroying the chromatographic fidelity. Electrospray mass spectrometry is an exciting new technique whereby molecularweight information can be obtained on proteins and other biopolymers with no apparent limit on size. This project will develop a technique for charging the droplets emerging from the Universal Interface and transmitting the resulting charged droplets and/or multiply-charged molecular ions to a quadrupole mass spectrometer. In this way, spectra on proteins and other large biomolecules will be obtained similar to those already demonstrated for electrospray, but without the restrictions on liquid flow and composition inherent in the conventional electrospray technique. The ultimate goal is an instrument for determining the molecular weights on subpicomolar components of complex biological extracts online with HPLC separation.Awardee's statement of the potential commercial applications of the research:There is a widely recognized need for a relatively inexpensive instrument that can provide reliable and accurate molecular weights on proteins and other biopolymers routinely in biomedical and biotechnical laboratories. Successful completion of this project should fill that need.National Institute of General Medical Sciences (NIGMS)

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----